Moreover, it is a downstream target of β-catenin and RAS/ERK signaling pathway in HCC, where the increased p-ERK1/2, results in elevated expression of cyclin D1 and the inhibitory phosphorylation of the tumor suppressor protein, pRb [77]. This evidence concerns the gene MAPK3 and hepatocellular carcinoma.